Adapt IP Joins CPA Global and Innography to participate in Ignite! 2018 on November 4 – 7 in Austin, TX. Adapt IP Founder and President, Grant Moss, will be presenting insights on the topic: “Friend or Foe: Finding the Right Licensing Partners”. For more information, please visit: https://www.cpaglobal.com/ignite2018.
Adapt IP Joins Summit on Protecting Innovations in the Financial Services Industry on July 25-26 in New York City. Every year, the Summit convenes in-house counsel to discuss the recent intellectual property and patent trends impacting the financial services industry. Attendees will gain updates on FinTech and emerging financial innovations, such as blockchain and artificial intelligence, and learn the underlying IP issues involved with these disruptive technologies. Additional valuable topics focus on developing patent strategies to protect your financial innovations by examining recent case law and the newest changes to the PTAB.
Adapt IP Founder and President, Grant Moss, will be participating in a panel entitled, “Increase Patent Portfolio Value by Optimizing and Strengthening Patent Assets Using Various Patent Office Procedures.”
Adapt IP is proud to sponsor this year’s IPBC Shenzhen. Devised for an audience of senior IP business leaders, IPBC Shenzhen will focus on how IP owners can strategically use intellectual property to secure greater flexibility, drive revenues, enhance bottom-line returns, increase shareholder value and provide leverage in the financial markets – find out more here
We are excited to be attending the IP Dealmaker Forum again this year. Please reach out if you are attending and would like to meet to discuss IP transaction and advisory projects. Email: email@example.com.
We are excited to be attending the LES annual meeting this year. Please reach out if you are attending and would like to meet to discuss IP transaction and advisory projects. Email: firstname.lastname@example.org.
Adapt IP Ventures, LLC, a patent transaction and advisory company, announced today that members of its team were named to the 2017 edition of IAM Strategy 300 — The World’s Leading IP Strategists. Adapt IP’s Founder & President, Grant Moss and Vice President, Brian Bochicco, were both named in the prestigious list of colleagues serving the IP-related needs of innovative companies.
In April 2017 two notable commercial announcements illustrated the potential challenges and financial strain surrounding the supplier-producer relationship and the underlying importance of the IP rights central to the partnership. The IP transaction announcements referenced below highlight the financial impacts of the value of intellectual property to technology companies and the suppliers of innovative technologies.
Innovative groups including companies of all sizes, universities and individuals seek to maximise the value of their intellectual property by investing in R&D activities and pursuing patent protection. Medical device companies are particularly focused on converting R&D efforts into patent-protected products. However, these companies and innovators face constant challenges resulting from numerous changes in regulations, pricing coverage, tax regimes and IP rights. As a result, corresponding IP values within the medical device industry appear to be declining based on a study of identified licensing transactions and royalty rates. To improve IP value, licensors must focus on demonstrating product and technology value to differentiate their licensing opportunity from others on the market and to command higher royalty rates, better deal terms and potential multiple licensing opportunities across different end markets and licensees.
Adapt IP Ventures, LLC, a patent transaction and advisory company, announced today that members of its team were named to the 2016 edition of IAM Strategy 300 — The World’s Leading IP Strategists. Adapt IP’s Founder & President, Grant Moss and Vice President, Brian Bochicco, were both named in the prestigious list of colleagues serving the IP-related needs of innovative companies. LINK TO ARTICLE